Healthy volunteers help test new drug absorption in early-stage trial

NCT ID NCT06749236

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well two different versions of an experimental oral drug (deuterium deuremidevir) are absorbed by the body. It involved 18 healthy Chinese adults aged 18 to 45. Participants took each version once, and researchers measured drug levels in their blood to compare the two. The goal was to gather information for future drug development, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Bengbu Medical College

    Xuzhou, Jiangsu, 233004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.